ASCO submitted its Patient-Centered Oncology Payment (PCOP) model for consideration by the Physician-Focused Payment Model Technical Advisory Committee (PTAC). PTAC is an advisory group to the Department of Health and Human Services (HHS), which sends recommendations to the Secretary of HHS on stakeholder proposals for a type of alternative payment model known as a physician-focused payment model (PFPM).
The ASCO Patient-Centered Oncology Payment: A Community-Based Oncology Medical Home Model is an oncology-specific PFPM, offering a complete solution for making the transition from fee-for-service to value-based cancer care delivery. Specifically, ASCO’s data show significant potential for PCOP to yield cost savings—up to 8% across the health-care system—while helping to ensure that patients have access to high-quality, high-value care.
“ASCO seeks to work with providers; federal, state, and private payers; employers; regional health networks; patient advisors; and others to build multistakeholder communities that would implement all or specific elements of the model,” said ASCO in its submission letter. “The support of PTAC and participation by the Medicare and Medicaid programs would advance this model in its intent to establish communities of providers and payers working together to improve cancer care delivery.”
PCOP’s design places particular emphasis on implementing “PCOP communities”—multidisciplinary networks of oncology providers and practices; federal, state, and private payers; employers; and regional health networks—aligned to support patient-centered care. This focus provides the following benefits:
© 2020. American Society of Clinical Oncology. All rights reserved.